GRI Bio(US:GRI)2026-01-15 15:02Summary of GRI Bio Inc. Extraordinary General Meeting Company Overview - Company Name: GRI Bio Inc. - Stock Symbol: NasdaqCM: GRI - Meeting Date: January 15, 2026 Key Points Discussed Meeting Attendance and Quorum - A total of 4,874,725 shares were present, representing 48.16% of the outstanding voting stock, confirming a quorum for the meeting [2] Proposals Voted Upon 1. Amendment Proposal: - Approval of an amendment to the Amended and Restated Certificate of Incorporation to effect a reverse stock split of the company's Common Stock at a ratio between 1 for 2 and 1 for 30. - The exact ratio will be determined by the Board of Directors, and they have the discretion to abandon the proposed amendment [3] 2. Adjournment Proposal: - Approval for the adjournment of the special meeting to a later date if necessary, to allow further solicitation and voting of proxies in case there are insufficient votes for the amendment proposal [4] Voting Process - Voting was conducted via proxy and electronic ballot, with an option for stockholders to vote during the meeting [5] - Preliminary results indicated that both the amendment and adjournment proposals received the requisite votes for approval [5] Conclusion of Meeting - Both proposals were declared duly approved, with final voting results expected to be reported on Form 8-K to the SEC within four business days [6] - The meeting concluded with appreciation expressed to stockholders for their participation [6][7] Additional Important Information - The meeting was attended by key executives including the CEO, CFO, and legal counsel, indicating a structured approach to governance and compliance [1] - The ability for the Board to abandon the reverse stock split proposal highlights a level of flexibility in corporate governance [3]